Physician profile

Scott A Soderquist

Orthodontics and Dentofacial Orthopedics · Joliet, IL

NPI 1477883270

$4,056.71

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$98.84

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
American Orthodontics Corporation $2,344.00 2019-2022
Ormco Corporation $936.91 2020-2022
Align Technology, INC. $713.41 2019-2024 Invisalign First - Comprehensive, Itero Element 5d Plus Lite, Invisalign
Kerr Corporation $33.21 2022
World Class Technology Corporation $22.07 2024 Pitts21, Pitts21 Pro
Voco America INC. $7.11 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Scott A Soderquist

$4,056.71

in general payments reported 2019-2025

Years
2019-2024
Top company
American Orthodontics Corporation

https://glasscript.com/doctor/1117392/scott-a-soderquist

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.